The Role of ACAID and Regulatory T Cells in CTL Function
Author Information
Author(s): Saban Daniel R., Cornelius Janet, Masli Sharmila, Schwartzkopff Johannes, Doyle Maire, Chauhan Sunil K., Peck Ammon B., Grant Maria B.
Primary Institution: University of Florida
Hypothesis
The study investigates the role of anterior chamber associated immune deviation (ACAID) and CD4+CD25+FOXP3+ regulatory T cells on cytotoxic T lymphocyte (CTL) function against MHC alloantigens.
Conclusion
ACAID inhibits CTL function against MHC alloantigens, and while Treg cells expand during ACAID induction, they do not directly mediate this inhibition.
Supporting Evidence
- ACAID is detectable up to 24 days following intracameral inoculation.
- CD4+ and CD8+ T cell percentages increased during ACAID induction but decreased during expression.
- Treg cells expanded during ACAID induction but did not directly inhibit CTL activity.
Takeaway
When certain immune cells are introduced into the eye, they can make the body less responsive to other immune cells that usually fight off foreign substances, like transplanted organs.
Methodology
C57BL/6 mice received intracameral inoculation with BALB/c splenocytes, and T cell populations were characterized using flow cytometry and proliferation assays.
Limitations
The study primarily focuses on a specific mouse model, which may not fully represent human immune responses.
Participant Demographics
Female C57BL/6 and BALB/c mice, six to eight weeks of age.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website